Healthcare provider profile · identity verified

Seth Hahs, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SALEM, IL · NPI 1154542132

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Seth Hahs, MD received $87.86 in general payments during 2025 across 4 reported records.

Novartis Pharmaceuticals Corporation accounted for 27.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Shingrix.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 152 claims for Arexvy by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Shingrix by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Trelegy Ellipta by this doctor in 2024.

Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Entresto by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$87.86

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novartis Pharmaceuticals Corporation	Unresolved — no canonical attribution shown	$24.35	27.7%	1	2025
Teva Pharmaceuticals USA, Inc.	Unresolved — no canonical attribution shown	$24.20	27.5%	1	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$20.91	23.8%	1	2025
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$18.40	20.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$87.86	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
LEQVIO Normalized: leqvio	Drug	Novartis Pharmaceuticals Corporation	$24.35	1	2025
Source payment records 2025-12-10 · Novartis Pharmaceuticals Corporation · $24.35 · Open Payments source
AUSTEDO XR Normalized: austedo xr	Drug	Teva Pharmaceuticals USA, Inc.	$24.20	1	2025
Source payment records 2025-09-12 · Teva Pharmaceuticals USA, Inc. · $24.20 · Open Payments source
AREXVY Normalized: arexvy	Biological	GlaxoSmithKline, LLC.	$20.91	1	2025
Source payment records 2025-10-21 · GlaxoSmithKline, LLC. · $20.91 · Open Payments source
BEXSERO Normalized: bexsero	Biological	GlaxoSmithKline, LLC.	$20.91	1	2025
Source payment records 2025-10-21 · GlaxoSmithKline, LLC. · $20.91 · Open Payments source
SHINGRIX Normalized: shingrix	Biological	GlaxoSmithKline, LLC.	$20.91	1	2025
Source payment records 2025-10-21 · GlaxoSmithKline, LLC. · $20.91 · Open Payments source
INCEPTIV Normalized: inceptiv	Device	Medtronic, Inc.	$18.40	1	2025
Source payment records 2025-07-07 · Medtronic, Inc. · $18.40 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
AREXVY arexvy	2025	Arexvy	2024	152	exact normalized	Medicare Part D
SHINGRIX shingrix	2025	Shingrix	2024	93	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	AREXVY open payments reported associated product	CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445	Arexvy · 2024 Exact normalized brand match · 1 Part D row	152	151
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	SHINGRIX open payments reported associated product	CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452	Shingrix · 2024 Exact normalized brand match · 1 Part D row	93	75
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS
Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference	2025	ENTRESTO open payments reported associated product	CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797	Entresto · 2024 Exact normalized brand match · 1 Part D row	34	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	974	215
Lisinopril	Lisinopril	730	160
Furosemide	Furosemide	595	118
Levothyroxine Sodium	Levothyroxine Sodium	497	101
Gabapentin	Gabapentin	494	93
Metoprolol Succinate	Metoprolol Succinate	474	108
Hydrochlorothiazide	Hydrochlorothiazide	473	130
Amlodipine Besylate	Amlodipine Besylate	461	102
Potassium Chloride	Potassium Chloride	449	72
Metformin Hcl	Metformin Hcl	373	88
Losartan Potassium	Losartan Potassium	366	87
Tramadol Hcl	Tramadol Hcl	361	77
Omeprazole	Omeprazole	330	85
Sertraline Hcl	Sertraline Hcl	301	60
Pantoprazole Sodium	Pantoprazole Sodium	296	74
Albuterol Sulfate Hfa	Albuterol Sulfate	294	85
Metoprolol Tartrate	Metoprolol Tartrate	279	61
Eliquis	Apixaban	253	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	244	44
Warfarin Sodium	Warfarin Sodium	241	23
Montelukast Sodium	Montelukast Sodium	228	55
Clopidogrel	Clopidogrel Bisulfate	217	46
Tamsulosin Hcl	Tamsulosin Hcl	208	48
Carvedilol	Carvedilol	200	41
Alprazolam	Alprazolam	192	31
Pravastatin Sodium	Pravastatin Sodium	191	36
Atenolol	Atenolol	179	45
Lovastatin	Lovastatin	162	36
Meloxicam	Meloxicam	154	39
Allopurinol	Allopurinol	153	35
Citalopram Hbr	Citalopram Hydrobromide	153	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	152	151
Rosuvastatin Calcium	Rosuvastatin Calcium	152	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	150	32
Buspirone Hcl	Buspirone Hcl	145	24
Fluticasone Propionate	Fluticasone Propionate	130	33
Famotidine	Famotidine	128	35
Trazodone Hcl	Trazodone Hcl	127	27
Clonidine Hcl	Clonidine Hcl	123	37
Simvastatin	Simvastatin	118	29
Spironolactone	Spironolactone	115	31
Escitalopram Oxalate	Escitalopram Oxalate	114	20
Glipizide	Glipizide	113	28
Prednisone	Prednisone	112	52
Metformin Hcl Er	Metformin Hcl	111	32
Azithromycin	Azithromycin	109	80
Oxybutynin Chloride	Oxybutynin Chloride	107	18
Zolpidem Tartrate	Zolpidem Tartrate	106	29
Pregabalin	Pregabalin	105	13
Tizanidine Hcl	Tizanidine Hcl	99	30
Donepezil Hcl	Donepezil Hcl	93	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	93	75
Memantine Hcl	Memantine Hcl	92	19
Ropinirole Hcl	Ropinirole Hcl	92	19
Methylprednisolone	Methylprednisolone	91	59
Januvia	Sitagliptin Phosphate	87	16
Fluoxetine Hcl	Fluoxetine Hcl	84	15
Duloxetine Hcl	Duloxetine Hcl	81	18
Jardiance	Empagliflozin	81	21
Levofloxacin	Levofloxacin	81	55
Amoxicillin	Amoxicillin	80	51
Lorazepam	Lorazepam	79	21
Meclizine Hcl	Meclizine Hcl	79	20
Mirtazapine	Mirtazapine	78	20
Celecoxib	Celecoxib	76	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	21
Cephalexin	Cephalexin	72	39
Ciprofloxacin Hcl	Ciprofloxacin Hcl	70	52
Clonazepam	Clonazepam	69	11
Finasteride	Finasteride	69	16
Ozempic	Semaglutide	69	16
Ezetimibe	Ezetimibe	68	21
Glimepiride	Glimepiride	67	18
Hydralazine Hcl	Hydralazine Hcl	67	16
Quetiapine Fumarate	Quetiapine Fumarate	67	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	13
Sumatriptan Succinate	Sumatriptan Succinate	64	suppressed
Symbicort	Budesonide/Formoterol Fumarate	63	20
Pioglitazone Hcl	Pioglitazone Hcl	60	18
Esomeprazole Magnesium	Esomeprazole Magnesium	59	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	59	29
Doxycycline Hyclate	Doxycycline Hyclate	58	22
Fenofibrate	Fenofibrate	58	13
Nystatin	Nystatin	58	23
Ondansetron Odt	Ondansetron	56	24
Sucralfate	Sucralfate	53	suppressed
Midodrine Hcl	Midodrine Hcl	49	suppressed
Xarelto	Rivaroxaban	49	14
Baclofen	Baclofen	48	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	48	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	11
Carbidopa-Levodopa	Carbidopa/Levodopa	45	suppressed
Fluconazole	Fluconazole	44	24
Enalapril Maleate	Enalapril Maleate	42	11
Nifedipine Er	Nifedipine	42	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	41	suppressed
Primidone	Primidone	41	suppressed
Propranolol Hcl	Propranolol Hcl	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	30
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Risperidone	Risperidone	36	suppressed
Tresiba Flextouch U-100	Insulin Degludec	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	13
Bupropion Xl	Bupropion Hcl	34	11
Entresto	Sacubitril/Valsartan	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Chlorthalidone	Chlorthalidone	33	11
Aripiprazole	Aripiprazole	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	20
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Minoxidil	Minoxidil	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Phenytoin	Phenytoin	28	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Torsemide	Torsemide	23	suppressed
Valsartan	Valsartan	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	22	22
Bumetanide	Bumetanide	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Topiramate	Topiramate	18	suppressed
Digoxin	Digoxin	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Linzess	Linaclotide	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Colchicine	Colchicine	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Novolog	Insulin Aspart	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Desipramine Hcl	Desipramine Hcl	13	suppressed
Invokana	Canagliflozin	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Phenobarbital	Phenobarbital	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Naproxen	Naproxen	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$87.86 · 4 records	Novartis Pharmaceuticals Corporation	AREXVY, AUSTEDO XR, BEXSERO, INCEPTIV, LEQVIO, SHINGRIX	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Arexvy play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error